Sponsor: National Institute of Minority Health and Health Disparities
Hawaiʻi Site Principal Investigator: Christine Akamine MD
Project Summary: Non-alcoholic fatty liver disease (NAFLD) [more recently called metabolic dysfunction-associated steatotic liver disease (MASLD)] is a condition of fat build-up in the liver not due to excessive alcohol consumption. It can lead to serious liver damage including liver cirrhosis and liver failure as well as to liver cancer. This study will assess the rates and factors associated with NAFLD in people living with HIV. The study will use a non-invasive ultrasound test to measure liver fibrosis (scarring) and amount of fat in the liver.
Inclusion Criteria:
Be 18 years or older at the time of the research study visit
Sponsor: National Institute of Minority Health and Health Disparities
Hawaiʻi Site Principal Investigator: Chuong Tran MD
Project Summary: Non-alcoholic fatty liver disease (NAFLD) [more recently called metabolic dysfunction-associated steatotic liver disease (MASLD)] is a condition of fat build-up in the liver not due to excessive alcohol consumption. It can lead to serious liver damage, including liver cirrhosis and liver failure, as well as to liver cancer. This study will use a non-invasive ultrasound test to measure liver fibrosis (scarring) and amount of fat in the liver. The study will assess the rates and co-morbidities associated NAFLD with the community health centers’ population in Hawaiʻi
Inclusion Criteria:
Be 13 years or older at the time of the research study visit.
Sponsor: National Institute on Minority Health and Health Disparities
Hawaiʻi Site Principal Investigator:Melissa Agsalda-Garcia
Project Summary:People living with HIV (PLWH) are faced with the health disparity of high anal cancer/dysplasia rates. It is known the human papillomavirus (HPV) is the causative agent for anal cancer/dysplasia but many PLWH are not vaccinated and there is limited data on its efficacy and effectiveness in PLWH. This project seeks to address this health disparity by understanding uptake barriers, improving their understanding of possible HPV vaccination benefits, and to determine the vaccine’s efficacy and effectiveness.
